Uranium & Nuclear Renaissance 2026–2029: Buying the Crash, Not the Hype

Thesis: Uranium equities crashed roughly 30 % in August 2026 (24/7 Wall St, 18.08.2026) while the fundamentals went the other way — the long-term contract price sat at an all-time high of 97 USD/lb for four straight months (NucNet, 01.10.2026; EIN Presswire, 02.10.2026), Kazakhstan cut 2026 output (Crux Investor, 13.08.2026) and BofA raised its forecast, seeing 50 % upside by 2027 (Investing.com, 06.08.2026). The term-spot gap of ~7.50 USD is the market's doubt; I take the other side with a barbell: physical (U-UN.TO, YCA.L) and producers (CCJ, PDN, UUUU) as the core, developers (NXE, DNN, BOE) for leverage, fuel-cycle and SMR names (LEU, BWXT, SMR, OKLO) as small option bets. Catalysts: Westinghouse IPO, utility contracting cycle Q4 2026/Q1 2027, HALEU offtakes, Rook I construction milestones, hyperscaler nuclear PPAs (Amazon/Constellation, 30.09.2026). Biggest risk: a spot price that stays below term for another year while SMR timelines slip — Oklo is not expected to book commercial revenue before 2028 (Motley Fool, 23.08.2026) and keeps selling stock (Yahoo Finance, 25.09.2026). Sizing: physical plus Cameco at least 40 % of the sleeve, no single developer above 8 %, SMR/OKLO/NNE combined under 10 %. Exit: trim producers if the long-term price prints below 80 USD/lb for two consecutive months; cut any SMR name that announces a further 12-month schedule slip.